Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Valvular Heart Disease: early-phase trial registry
7 of 9 indexed Valvular Heart Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 7 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Valvular Heart Disease: 9 US clinical trials tracked, 7 recruiting.
Valvular Heart Disease is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 2 of these trials.
Enrollment posture brief
Registry condition valvular-heart-disease
OPEN 7 | RECR 78% | LATE 0 | EARLY 1 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)
Valvular Heart Disease lists 7 open slots (78% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Valvular Heart Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Valvular Heart Disease is recruiting above its size-band peers.
7 of 9 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Valvular Heart Disease research.
Abbott Medical Devices accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Valvular Heart Disease enrolment sits around 550 participants.
Median target enrolment is 550 among the 9 trials that report a genuine target (sentinel values excluded). 1 of those (11.1%) plan for fewer than 100 participants.
-
Valvular Heart Disease research leans observational.
2 interventional and 7 observational studies make up this index (22.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Abbott Structural Heart Device Registry
Abbott Medical Devices
NCT06590467
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Peerbridge Health
NCT06699056
Development of CIRC Technologies
The Cleveland Clinic
NCT05654272
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Abbott Medical Devices
NCT04761120
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
Tulane University
NCT04843371
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Vanderbilt University Medical Center
NCT06077201
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
Inova Health Care Services
NCT06675448
Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE
Cardiovascular Research Foundation, New York
NCT05357404
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Marc Sakwa, MD
NCT01681095
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Valvular Heart Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Valvular Heart Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Valvular Heart Disease page
9 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Valvular Heart Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Abbott Medical Devices sponsors the most Valvular Heart Disease trials on record, review their full trial history before evaluating a specific study. See Abbott Medical Devices's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Valvular Heart Disease condition card totals 9 registered trials; most-linked intervention Cold Blood Cardioplegia; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.